Oshkosh Trims FY21 Adj. EPS Outlook; Declares Dividend - Quick Facts

While reporting financial results for the third quarter on Thursday, Oshkosh Corp. (OSK) trimmed its adjusted earnings guidance for the full-year 2021, reflecting the ongoing supply chain-related challenges. The company also declared a quarterly cash dividend.

For fiscal 2021, the company now projects earnings in a range of $7.15 to $7.30 per share and adjusted earnings in a range of $6.35 to $6.50 per share.

Previously, the company expected projects earnings in a range of $6.10 to $6.60 per share and adjusted earnings in a range of $6.35 to $6.85 per share on projected net sales between $7.75 billion and $7.95 billion.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $6.84 per share on net sales of $7.88 billion for the year. Analysts' estimates typically exclude special items.

Further, the Company's Board of Directors today declared a quarterly cash dividend of $0.33 per share of Common Stock, payable on August 30, 2021, to shareholders of record as of August 16, 2021.

"Demand is strong across the markets where we compete, and we remain confident in the outlook for these markets. In particular, we are pleased with growing demand for access equipment, which we believe will remain strong for the foreseeable future," said John Pfeifer, president and CEO.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Covid vaccine makers Pfizer Inc. and BioNTech SE announced a new $3.2 billion vaccine supply deal with the U.S. Government, as the country is bracing for a Covid outbreak this fall. Under the deal, the U.S. government will receive 105 million doses (30 µg, 10 µg and 3 µg) of Pfizer -BioNTech covid vaccines initially. The order may include adult Omicron-adapted COVID-19 vaccines. Samsung Electronics Co. has started the initial mass production of 3-nanometer or nm chips, which is considered as the most advanced chip in the world. In its move, the South Korean tech major beats rival Taiwan Semiconductor Manufacturing Co., the world's largest chip manufacturer, which is reportedly in the process to build one. Bryant Ranch Prepack Inc. is recalling certain Morphine Sulfate Extended-Release Tablets citing incorrect labeling, the U.S. Food and Drug Administration said. The recall involves one lot of Morphine Sulfate 30 mg Extended-Release tablets, and one lot of Morphine Sulfate 60 mg Extended-Release tablets to the consumer level.
Follow RTT